Search
Clindamycin phosphate is a chemically semi-synthetic clindamycin derivative, white or off-white crystalline powder at room temperature, odorless, bitter taste, hygroscopic. There is no antibacterial activity in vitro, and it can be rapidly hydrolyzed to clindamycin after entering the body to exert pharmacological effects. Its mechanism of action, antibacterial spectrum, indications, and therapeutic effect are the same as clindamycin, but its fat solubility and permeability are better than clindamycin, and can be administered orally or intramuscularly and intravenously, mainly metabolized in the liver, excreted through bile and feces, and partially excreted in the urine. Compared with lincomycin, clindamycin phosphate has a strong antibacterial effect of 4~8 times, good absorption, high bone tissue concentration, and strong antibacterial activity against gram-positive cocci and anaerobic bacteria.
Clindamycin phosphate is mainly used for the treatment of tonsillitis, purulent otitis media, sinusitis, acute bronchitis, acute exacerbations of chronic bronchitis, pneumonia, lung abscess, bronchiectasis co-infection, skin and soft tissue infections, etc.
Items | Specifications | Results |
Appearance | White to off-white crystalline powder | White crystalline powder |
Identification | IR:Meets the requirements | |
HPLC:retention time conforms to RS | Conform | |
Crystallinity | Conform | Conform |
PH | 3.5~4.5 | 4.0 |
Water | ≤ 6.0% | 0.41% |
Assay | ≥758μg/mg clindamycin on the anhydrous substance | 836μg/mg |
Organic Impurities | Lincomycin phosphate ≤1.0% | 0.049% |
Lincomycin ≤0.5% | N.D. | |
Clindamycin B phosphate ≤1.5% | 0.053% | |
7-Epiclindamycin phosphate ≤0.8% | 0.21% | |
Clindamycin 3-phosphate ≤0.3% | ||
Clindamycin ≤0.5% | N.D. | |
Any indivdual,unspecified impurity ≤1.0% | N.D. | |
Total impurities ≤4.0% | 0.31% | |
Residual solvents | Methanol ≤3000ppm | 0.3 |
Ethanol ≤5000ppm | 580ppm | |
Acetone ≤5000ppm | N.D. | |
Conclusion | The product conforms to the above specifications. | |
| Product parameters | |
| Cas number: | 24729-96-2 |
| Appearance: | White crystalline powder |
| Purity: | ≥758ug/mg |
| Package details: | 25kg/drum |
| Brand: | Fortunachem |
Clindamycin phosphate is a water-soluble prodrug ester of the antibiotic clindamycin. It is inactive until converted by enzymes in the body into biologically active clindamycin.
Class: Lincosamide antibiotic.
Key Advantage: The phosphate ester form allows for parenteral administration (injection) and topical formulation, as it is much more soluble than clindamycin base.
Once converted to active clindamycin, it works by binding to the 50S subunit of the bacterial ribosome. This inhibits bacterial protein synthesis, preventing bacteria from growing and multiplying (it is primarily bacteriostatic).
1. Topical Formulations (Most Common Use):
Acne Vulgaris: A first-line topical treatment for inflammatory acne (gels, lotions, foams). Often combined with benzoyl peroxide.
Bacterial Vaginitis: Used as a vaginal cream or suppository.
Skin Infections: Topical solutions for minor bacterial skin infections.
2. Parenteral (Injectable) Formulations:
Used for serious systemic infections caused by anaerobic bacteria and certain gram-positive aerobes, including:
Severe Skin & Soft Tissue Infections (e.g., abscesses, cellulitis).
Intra-abdominal Infections (often mixed anaerobic/aerobic).
Pelvic Inflammatory Disease (PID).
Bone & Joint Infections.
As an alternative for patients allergic to penicillin.
3. Oral Form (Clindamycin HCl):
For similar systemic infections when oral therapy is appropriate.
Clostridioides difficile-Associated Diarrhea (CDAD): A major risk. Can cause severe, potentially fatal colitis. Use is reserved for cases where benefits outweigh risks.
Allergy: Contraindicated in patients with hypersensitivity to clindamycin or lincomycin.
Spectrum: Primarily targets anaerobic bacteria and gram-positive cocci (e.g., Staphylococcus aureus, streptococci). NOT effective against gram-negative bacilli.
Prescription Only: Requires medical supervision.
| Feature | Description |
|---|---|
| What it is | A soluble prodrug of the antibiotic clindamycin. |
| Main Mechanism | Inhibits bacterial protein synthesis (bacteriostatic). |
| Topical Uses | Acne vulgaris, bacterial vaginosis, minor skin infections. |
| Systemic (IV/IM/Oral) Uses | Serious anaerobic & gram-positive infections (skin, abdomen, bone, pelvis). |
| Critical Warning | High risk of causing C. difficile colitis (severe diarrhea). |
| Availability | Prescription-only, in topical (gel, lotion, cream), vaginal, and injectable forms. |
Disclaimer: This information is for educational purposes. Clindamycin is a potent antibiotic with significant risks and must be used only under the direction of a healthcare professional.




Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية